Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France
This completed clinical trial describes saxagliptin utilization and assesses its impact on health status in patients with Type 2 Diabetes Me…
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: Effects of Medical and Surgical Weight Loss on Metabolism
A completed clinical trial evaluating the metabolic effects of medical versus surgical weight loss in adults with type 2 diabetes mellitus a…
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: Effect of Short Peripheral Electrical Stimulation (PES) on Blood Glucose [NA]
Completed clinical trial evaluating the effect of short peripheral electrical stimulation on blood glucose in individuals with Type 2 Diabet…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy [Phase 3]
Phase 3 clinical trial evaluating adding metformin to SYR-322 in type 2 diabetes patients inadequately controlled on SYR-322 plus lifestyle …
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Effects of Physical Activity Coaching on Health and Behaviour Parameters in Diabetic Persons [NA]
Clinical trial update on a completed study evaluating the effects of physical activity coaching on health and behaviour parameters in adults…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug [Phase 3]
Phase 3 Japanese study of rimonabant added to oral antidiabetic therapy in obese patients with type 2 diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing fasiglifam (TAK-875) to placebo and sitagliptin, added to metformin, in type 2 diabetes; the study was terminated an…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating ITCA 650 compared to sitagliptin as add-on therapy for Type 2 diabetes has completed.
-
FDA approval · 2016-06-01FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for BASAGLAR KWIKPEN (insulin glargine) filed by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating fasiglifam (TAK-875) in combination with sitagliptin for adults with Type 2 diabetes mellitus was terminated, with …
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing TAK-875 to glimepiride, both added to metformin, in type 2 diabetes; the study was terminated but efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Preventing ESRD in Overt Nephropathy of Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating prevention of end-stage renal disease in patients with type 2 diabetes and overt diabetic nephropathy has complet…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial of TAK-875 added to glimepiride in type 2 diabetes was terminated, with results posted in 2016.
-
CLINICAL_TRIALS research · 2016-05-30Clinical Trial Update: Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose
The clinical trial evaluated targeted screening of Type 2 Diabetes using capillary blood glucose, and the study status is completed.
-
FDA approval · 2016-05-27FDA Approved: JENTADUETO XR — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved JENTADUETO XR (linagliptin and metformin hydrochloride extended-release) under an original application for adults with type…
-
FDA approval · 2016-05-27FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for alogliptin from Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS withdrawal · 2016-05-27Clinical Trial Update: Medication in Early Diabetes (MED) Study [Phase 4]
A Phase 4 clinical trial called Medication in Early Diabetes (MED) investigating Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of M100907 for sleep maintenance insomnia, including a sub-study in individuals with …
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Volinanserin for sleep maintenance insomnia, with a sub-study in stable Type 2 diabetes …
-
CLINICAL_TRIALS research · 2016-05-26Clinical Trial Update: Effect of Liraglutide on Clock Genes [NA]
A Tel Aviv University study investigates the effect of liraglutide on clock (circadian) genes in individuals with type 2 diabetes; phase and…
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus [NA]
An update for NCT02054650 indicates that the trial evaluating osteopathic manipulative treatment for chronic low back pain in patients with …
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
A pregnancy registry study of exenatide in women with type 2 diabetes during pregnancy was terminated; the registry tracked birth defects an…
-
FDA approval · 2016-05-20FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKANA (canagliflozin) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2016-05-20FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc. The…
-
CLINICAL_TRIALS research · 2016-05-20Clinical Trial Update: Meta-analyses of the Effect of Liquid Meal Replacements on Cardiometabolic Risk
This document presents a meta-analysis of the effect of liquid meal replacements on cardiometabolic risk factors in adults with overweight o…